These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19821391)

  • 1. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Miller N; Robson S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006937. PubMed ID: 19821391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Parker NK; Kelly H; Miller N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech and language therapy to improve the communication skills of children with cerebral palsy.
    Pennington L; Goldbart J; Marshall J
    Cochrane Database Syst Rev; 2004; 2004(2):CD003466. PubMed ID: 15106204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for childhood apraxia of speech.
    Morgan AT; Murray E; Liégeois FJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD006278. PubMed ID: 29845607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002088. PubMed ID: 16034872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech and language therapy interventions for children with primary speech and language delay or disorder.
    Law J; Garrett Z; Nye C
    Cochrane Database Syst Rev; 2003; 2003(3):CD004110. PubMed ID: 12918003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention for dysarthria associated with acquired brain injury in children and adolescents.
    Morgan AT; Vogel AP
    Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006279. PubMed ID: 18646143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for improving communication with children and adolescents about their cancer.
    Ranmal R; Prictor M; Scott JT
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD002969. PubMed ID: 18843635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-mediated early intervention for young children with autism spectrum disorders (ASD).
    Oono IP; Honey EJ; McConachie H
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009774. PubMed ID: 23633377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2002; (4):CD002088. PubMed ID: 12519567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Views of children with cerebral palsy and their parents on the effectiveness and acceptability of intensive speech therapy.
    Pennington L; Rauch R; Smith J; Brittain K
    Disabil Rehabil; 2020 Oct; 42(20):2935-2943. PubMed ID: 30925074
    [No Abstract]   [Full Text] [Related]  

  • 16. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2001; (2):CD002088. PubMed ID: 11406032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Powered mobility interventions for very young children with mobility limitations to aid participation and positive development: the EMPoWER evidence synthesis.
    Bray N; Kolehmainen N; McAnuff J; Tanner L; Tuersley L; Beyer F; Grayston A; Wilson D; Edwards RT; Noyes J; Craig D
    Health Technol Assess; 2020 Oct; 24(50):1-194. PubMed ID: 33078704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for promoting participation in shared decision-making for children with cancer.
    Coyne I; O'Mathúna DP; Gibson F; Shields L; Sheaf G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008970. PubMed ID: 23740765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention for childhood apraxia of speech.
    Morgan AT; Vogel AP
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006278. PubMed ID: 18646142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke.
    Baxi R; Sharma M; Roseby R; Polnay A; Priest N; Waters E; Spencer N; Webster P
    Cochrane Database Syst Rev; 2014 Mar; (3):CD001746. PubMed ID: 24671922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.